| Nutraceutical or Pharmacological Potential of Moringa oleifera Lam. X Kou, B Li, JB Olayanju, JM Drake, N Chen Nutrients 10 (3), 343, 2018 | 406 | 2018 |
| Phosphoproteome integration reveals patient-specific networks in prostate cancer JM Drake, EO Paull, NA Graham, JK Lee, BA Smith, B Titz, T Stoyanova, ... Cell 166 (4), 1041-1054, 2016 | 232 | 2016 |
| ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells JM Drake, G Strohbehn, TB Bair, JG Moreland, MD Henry Molecular biology of the cell 20 (8), 2207-2217, 2009 | 218 | 2009 |
| Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells T Stoyanova, AR Cooper, JM Drake, X Liu, AJ Armstrong, KJ Pienta, ... Proceedings of the National Academy of Sciences 110 (50), 20111-20116, 2013 | 193 | 2013 |
| DNA-PKcs-mediated transcriptional regulation drives prostate cancer progression and metastasis JF Goodwin, V Kothari, JM Drake, S Zhao, E Dylgjeri, JL Dean, ... Cancer cell 28 (1), 97-113, 2015 | 184 | 2015 |
| Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression JM Drake, NA Graham, T Stoyanova, A Sedghi, AS Goldstein, H Cai, ... Proceedings of the National Academy of Sciences 109 (5), 1643-1648, 2012 | 184 | 2012 |
| Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal via β-catenin signaling T Stoyanova, AS Goldstein, H Cai, JM Drake, J Huang, ON Witte Genes & development 26 (20), 2271-2285, 2012 | 169 | 2012 |
| Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets JM Drake, NA Graham, JK Lee, T Stoyanova, CM Faltermeier, S Sud, ... Proceedings of the National Academy of Sciences 110 (49), E4762-E4769, 2013 | 131 | 2013 |
| MAPK reliance via acquired CDK4/6 inhibitor resistance in cancer R De Leeuw, C McNair, MJ Schiewer, NP Neupane, LJ Brand, ... Clinical Cancer Research 24 (17), 4201-4214, 2018 | 119 | 2018 |
| Clinical targeting of mutated and wild-type protein tyrosine kinases in cancer JM Drake, JK Lee, ON Witte Molecular and cellular biology 34 (10), 1722-1732, 2014 | 119 | 2014 |
| Purification and direct transformation of epithelial progenitor cells from primary human prostate AS Goldstein, JM Drake, DL Burnes, DS Finley, H Zhang, RE Reiter, ... Nature protocols 6 (5), 656-667, 2011 | 116 | 2011 |
| MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancer NG Nickols, R Nazarian, SG Zhao, V Tan, V Uzunangelov, Z Xia, ... Prostate cancer and prostatic diseases 22 (4), 531-538, 2019 | 101 | 2019 |
| Assessing tumor growth and distribution in a model of prostate cancer metastasis using bioluminescence imaging JM Drake, CL Gabriel, MD Henry Clinical & experimental metastasis 22, 674-684, 2005 | 100 | 2005 |
| ZEB1 coordinately regulates laminin-332 and β4 integrin expression altering the invasive phenotype of prostate cancer cells JM Drake, JM Barnes, JM Madsen, FE Domann, CS Stipp, MD Henry Journal of Biological Chemistry 285 (44), 33940-33948, 2010 | 94 | 2010 |
| Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade H Lue, J Podolak, K Kolahi, L Cheng, S Rao, D Garg, CH Xue, JK Rantala, ... Genes & Development 31 (20), 2067-2084, 2017 | 81 | 2017 |
| Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer T Stoyanova, M Riedinger, S Lin, CM Faltermeier, BA Smith, KX Zhang, ... Proceedings of the National Academy of Sciences 113 (42), E6457-E6466, 2016 | 62 | 2016 |
| Functional screen identifies kinases driving prostate cancer visceral and bone metastasis CM Faltermeier, JM Drake, PM Clark, BA Smith, Y Zong, C Volpe, ... Proceedings of the National Academy of Sciences 113 (2), E172-E181, 2016 | 59 | 2016 |
| Gain-of-function mutant p53 activates small GTPase Rac1 through SUMOylation to promote tumor progression X Yue, C Zhang, Y Zhao, J Liu, AW Lin, VM Tan, JM Drake, L Liu, ... Genes & development 31 (16), 1641-1654, 2017 | 49 | 2017 |
| Targeting RET kinase in neuroendocrine prostate cancer HR VanDeusen, JR Ramroop, KL Morel, SY Bae, AV Sheahan, Z Sychev, ... Molecular Cancer Research 18 (8), 1176-1188, 2020 | 47 | 2020 |
| Integrin α3β1 regulates tumor cell responses to stromal cells and can function to suppress prostate cancer metastatic colonization A Varzavand, JM Drake, RU Svensson, ME Herndon, B Zhou, MD Henry, ... Clinical & experimental metastasis 30, 541-552, 2013 | 46 | 2013 |
Michael HenryUniversity of Iowa, Carver College of MedicineEmail yang diverifikasi di uiowa.edu
